Clinical
Cardiology | Dermatology | Diabetes | Gastroenterology | Ophthalmology | Psychiatry | Pulmonology | Rheumatology
View All >>
Spotlight
COVID-19 | Sickle Cell Disease

Clinical News

View All >>

Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder

8 hours ago

By Kevin Kunzmann

The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.

The Challenges to Identifying Dementia, Alzheimer-Risk Patients

8 hours ago

By Kevin Kunzmann

Dementia and Alzheimer's disease cases are anticipated to boom in coming decades. One expert stressed the need for improved screening and facilitation of care at the earliest stages and signs.

CP101 Prevented Recurrence of C Difficile Infection in PRISM-EXT Trial

9 hours ago

By Connor Iapoce

Data show the proportion of individuals with sustained clinical cure through Week 8 was 80.3% with CP101 treatment.

Guiding Appropriate Ketamine, Esketamine Use in Psychiatry

9 hours ago

By Kevin Kunzmann

The lead author of treatment recommendations weighs in on their current use and future research.

Raseen Tariq, MBBS: FMT for Refractory Host Versus Graft Disease

9 hours ago

By Kenny Walter

Initial studies have shown a 73% efficacy for FMT in treating patients with HVGD.

Conference Coverage
View All >>

Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder

8 hours ago

By Kevin Kunzmann

The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.

The Challenges to Identifying Dementia, Alzheimer-Risk Patients

8 hours ago

By Kevin Kunzmann

Dementia and Alzheimer's disease cases are anticipated to boom in coming decades. One expert stressed the need for improved screening and facilitation of care at the earliest stages and signs.

CP101 Prevented Recurrence of C Difficile Infection in PRISM-EXT Trial

9 hours ago

By Connor Iapoce

Data show the proportion of individuals with sustained clinical cure through Week 8 was 80.3% with CP101 treatment.

Guiding Appropriate Ketamine, Esketamine Use in Psychiatry

9 hours ago

By Kevin Kunzmann

The lead author of treatment recommendations weighs in on their current use and future research.

Video Series
View All >>
Patient Diagnosis and Early Treatment of Atopic Dermatitis
Patient Presentation of Atopic Dermatitis
Optimizing the Management of TRD
Payer Strategies to Reduce Delay to TRD Therapy
Role of JAK Inhibitors for Atopic Dermatitis Treatment
Treatment Goals and Challenges for Atopic Dermatitis Management
Novel Agents for the Management of Pediatric and Adult ADHD
Role of Viloxazine in Adult ADHD Treatment
Managing Patients with ADHD on Viloxazine
Implementing Lifestyle Modifications for ASCVD and Hypercholesterolemia Management
DCRM Practice Recommendations for ASCVD and Metabolic Diseases
Guidelines and Management of Patients With Polyvascular Disease
Provider Engagement and Screening
Role of Genetic Mutations in HCM Pathophysiology
Overview of Hypertrophic Cardiomyopathy
Video Interviews
View All >>
Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder
The Challenges to Identifying Dementia, Alzheimer-Risk Patients
Guiding Appropriate Ketamine, Esketamine Use in Psychiatry
Raseen Tariq, MBBS: FMT for Refractory Host Versus Graft Disease
Miguel Regueiro, MD: Safety Data on Ozanimod for Ulcerative Colitis
Taha Qazi, MD: Male Sexual Dysfunction Following Ulcerative Colitis Surgery
Ken Blount, PhD: Effect of RBX2660 on Microbiome and Bile Acid Composition
How Evolving Psychiatric Definitions Set the Tone for Care
Adjunctive Cariprazine with Antidepressants Benefits Adult Major Depressive Disorder
How Mental Illness Definitions Are Still Being Uncovered and Refined
The Pediatric Disaster Psychiatry Care Team
Understanding Socially-Determined Mental Health and the Impact of COVID-19
Zuranolone Benefits Major Depression, Postpartum Depression in Clinical Program
The Need for Disaster Psychiatry Care
Eco-Anxiety and Contributing Mental Health Factors Among BIPOC
Podcasts
View All >>
How PREPARE Data, SMART Recommendations Alter Modern Asthma Strategy
Improving the Availability of COVID-19 Therapeutics in Vulnerable Communities
An Interview with a Medical Volunteer at the Ukraine-Poland Refugee Border
New Methods for Overcoming Environmental and Food Allergies
Evaluating the Efficacy of Faricimab in Patients with DME from Underrepresented Communities
How Determi-Nation Promotes Diversity in Psoriasis Research and Treatment
NAFLD Prevalence Increasing in Pediatric Patients
How Treating, Diagnosing Sarcoidosis Is Still Evolving
Approximately 9 Million More Americans Exposed to Air Pollution in 2018 - 2020
How JAK Inhibitors Revolutionized Dermatology Care
hcplive podcasts